Comments
Shares of Aurobindo Pharma Ltd have perked up by Rs 8.55 to Rs 139.20 (face value Re 1) on the BSE after the company informed that the USFDA has lifted the import alert for non-sterile products manufactured at one of its units in Hyderabad.
Quoting USFDA Web site, the company said that the import alert for non-sterile products produced at its unit-VI cephalosporin facility in Hyderabad I has been lifted, enabling resumption of exports of nine products to the US market.
Before the import alert was issued in February 2011, the unit had annual US sales of $33 million for the above mentioned products, APL said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.